Cross-sectional analysis shows disparities in mortality for sickle cell disease and cystic fibrosis, highlighting treatment progress.
This cross-sectional study examines differences in mortality rate trends for sickle cell disease and cystic fibrosis in the US, highlighting disparities in treatment progress, cost, and patient access to care.
No takes yet. Share an insight, caveat, or question.
Abraha et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: